Austrian Biotech Database

Biotechgate

Biotechgate Global Database › Global Trial › Global Log-in ›

Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry
Results 61 - 80 out of 120 displayed.
« 1 2 3 4 5 6 »

Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two phase III trials in MASH for survodutide

Read more ››

By: GlobeNewswire - 08 Oct 2024

Novo Nordisk launches new initiative to prevent childhood obesity in disadvantaged urban communities

Read more ››

By: GlobeNewswire - 08 Oct 2024

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobeNewswire - 07 Oct 2024

Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility

Read more ››

By: GlobeNewswire - 02 Oct 2024

Related companies: Emergent BioSolutions Inc. | Erste Group Bank AG

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobeNewswire - 30 Sep 2024

SS Innovations Welcomes Mr. Tim Adams, Leader in the Health Care Industry, to Board

Read more ››

By: GlobeNewswire - 30 Sep 2024

Boehringer Ingelheim partners with NCD Alliance to target Non-Communicable Diseases in underserved communities

Read more ››

By: GlobeNewswire - 27 Sep 2024

Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional TEMBEXA® (brincidofovir) to Support National Preparedness Efforts

Read more ››

By: GlobeNewswire - 26 Sep 2024

Related companies: Emergent BioSolutions Inc. | Erste Group Bank AG

Boehringer Ingelheim expands cancer research at its Vienna site

Read more ››

By: GlobeNewswire - 25 Sep 2024

Emergent BioSolutions Confirms Approximately $400 million in Orders in 2024 & 2025 to Support Smallpox and Mpox Preparedness Efforts

Read more ››

By: GlobeNewswire - 25 Sep 2024

Related companies: Emergent BioSolutions Inc. | Erste Group Bank AG

Novo Nordisk A/S - share repurchase programme

Read more ››

By: GlobeNewswire - 23 Sep 2024

Revolutionizing Surgery: SS Innovations International Inc. Celebrates 2,000 Procedures with its SSi Mantra Surgical Robotic System

Read more ››

By: GlobeNewswire - 23 Sep 2024

Novo Nordisk A/S: Monlunabant phase 2a trial in obesity successfully completed

Read more ››

By: GlobeNewswire - 20 Sep 2024

Novo Nordisk A/S: Wegovy® recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical function

Read more ››

By: GlobeNewswire - 19 Sep 2024

Green Science Alliance Developed Quantum Dots Based Nail Cosmetic Products. First Time In The World

Read more ››

By: PR Newswire Association LLC. - 17 Sep 2024

Novo Nordisk A/S - share repurchase programme

Read more ››

By: GlobeNewswire - 16 Sep 2024

Lexogen launches LUTHOR HD Pool and a dedicated LUTHOR single cell dispenser: Expanding High-Throughput Single-cell RNA Sequencing Solutions

Read more ››

By: PR Newswire Association LLC. - 16 Sep 2024

Related companies: Lexogen GmbH

Boehringer’s nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER™-IPF study

Read more ››

By: GlobeNewswire - 16 Sep 2024

Emergent BioSolutions Announces Agreement to Settle Securities Class Action Litigation

Read more ››

By: GlobeNewswire - 13 Sep 2024

Related companies: Emergent BioSolutions Inc. | Erste Group Bank AG

F2G Announces $100 Million Financing to Advance Late-Stage Development and Commercialization of Novel Antifungal Drug Candidate Olorofim in the US

Read more ››

By: GlobeNewswire - 12 Sep 2024

Related companies: F2G Ltd | F2G Biotech GmbH

« 1 2 3 4 5 6 »

Looking for companies outside of Austria?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

February 2025
- Biotechgate Digital Partnering February 2025
- Zurich: 18th Annual European Life Sciences CEO Forum
March 2025
- Miami: Investival Showcase USA

Add an Event »

Latest company news

Novo Nordisk A/S: Semaglutide 7.2 mg s.c. achieved 20.7% weight loss in the STEP UP obesity trial, and 18.7% regardless of treatment adherence
17 Jan 2025 (GlobeNewswire)

Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA)
16 Jan 2025 (GlobeNewswire)

Boehringer provides update on iclepertin Phase III program in schizophrenia
16 Jan 2025 (GlobeNewswire)

Biotechgate database

About Biotechgate
The Austrian Biotech Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com